The Variant Bio Blog

How Stacey Drabic, Variant Bio’s VP of Biology, works across teams and therapeutic areas to advance drug discovery and development

Our recent Commentary in Cell provides practical examples of how to share results with communities participating in genomic research

How Variant Bio is leveraging multi-omics data from studies with diverse populations to boost drug discovery and development

Highlights from a talk marking the 30th anniversary of International Day of the World’s Indigenous Peoples

Luan Phan, from Variant Bio’s R&D team, discusses his work on assay development and drug discovery

Isabella Apriyana discusses her experiences coordinating a genomic research collaboration between MRIN in Indonesia and Variant Bio

Focusing our efforts at BIO 2024 to catalyze strategic collaborations around drug discovery and development

Seeing in person how an ongoing project in the Faroe Islands will lead to genomic findings and improve health

The importance of optimizing compounds’ design and determining the viability of drug candidates for use in humans

In honor of Earth Day on April 22, biologist RC Chin-Wen Lai discusses the environmental impact of scientific innovation

Press release details collaboration aimed at addressing unmet medical need in fibrotic indications

Chemists on Variant Bio’s R&D team are discovering new molecules to advance toward clinical development

What can companies like Variant Bio do to treat research participants and communities with respect?

Our recent article in Genome Research provides a practical example of community-driven benefit sharing for researchers around the world

How Rachel Eguia, Carole Smith, and Leah Rommereim pursued careers in science, and what excites them most about their work at Variant Bio

How Jennifer Brady, Variant Bio’s new Director of Biology, is working on bringing positive, tangible outcomes to patients around the world

Variant Bio Fellow Isabella Apriyana discusses lessons learned working with communities participating in genomic research across Indonesia

How Chief Business Officer Steve Bryant is working to maximize the impact of Variant Bio’s mission through strategic industry alliances

How we are working with collaborators on a study focused on gout and chronic kidney disease in New Caledonia

Highlights of the American Society of Nephrology’s annual meeting from Variant Bio’s Chief Scientific Officer

How Variant Bio and study collaborators are carrying out ongoing community engagement for a genomic research project in northern Kenya

How population geneticists at Variant Bio apply GWAS methods to identify positively selected variants that are also associated with disease

How we are working to better understand the relationship between genes and health in the Pukapuka community of Aotearoa New Zealand

How Prof. Lyn Griffiths is returning study results from a collaboration with Variant Bio to participating communities on Norfolk Island